Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Tomáš Páleníček

Biographic Data

ID7644845
NAMETomáš Páleníček
GIVEN NAMESTomáš
FAMILY NAMEPáleníček
SIGNATUREPÁLENÍČEK T
AFFILIATIONSCharles University
ORCID0000-0002-3109-9539
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic

    Open Access•Zuzana Postránecká, Matyáš Lucký et al.•ARTICLE•Journal of Psychedelic Studies•2026

    The Czech Republic, like many European countries, continues to face significant challenges in treating substance use disorders (SUDs), with high relapse rates and complex comorbidities often linked to trauma and mental illness. Psychedelic-assisted psychotherapy (PAP) has re-emerged internationally as a promising therapeutic modality, although available evidence remains heterogeneous across substances, populations, and study designs. This narrati…

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

    Open Access•Guy M Goodwin, Scott T Aaronson et al.•ARTICLE•New England Journal of Medicine•2022

    BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression. METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formulation of psilocybin at a dose of 25 mg, 10 mg, or 1 mg (control), along with psychological support. The primary end point was the change from baseline to week 3 in the total score on the Montgomery-Å…

  • Mephedrone (4-Methylmethcathinone)

    Open Access•Klára Šíchová, Nikola Pinterová et al.•ARTICLE•Frontiers in Psychiatry•2018

    Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH's and its primary metabolite nor-mephedrone's (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum, brain, lungs, and liver), as well as comparative analysis of their effects on locomotion [open field test (OFT)] and sensorimotor gating [prepulse i…

  • Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat

    Open Access•Rachel R Horsley, Eva Lhotková et al.•ARTICLE•Frontiers in Psychiatry•2018

    3,4-methylenedioxypyrovalerone (MDPV) is a potent pyrovalerone cathinone that is substituted for amphetamines by recreational users. We report a comprehensive and detailed description of the effects of subcutaneous MDPV (1-4 mg/kg) on pharmacokinetics, biodistribution and metabolism, acute effects on thermoregulation under isolated and aggregated conditions, locomotion (open field) and sensory gating (prepulse inhibition, PPI). All studies used m…

  • Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats

    Open Access•Kristýna Štefková, Monika Žídková et al.•ARTICLE•Frontiers in Psychiatry•2017

    Methylone (3,4-methylenedioxy- N -methylcathinone) is a synthetic cathinone analog of the recreational drug ecstasy. Although it is marketed to recreational users as relatively safe, fatalities due to hyperthermia, serotonin syndrome, and multi-organ system failure have been reported. Since psychopharmacological data remain scarce, we have focused our research on pharmacokinetics, and on a detailed evaluation of temporal effects of methylone and …

No prominent works on this page.

  • Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats

    Open Access•Kristýna Štefková, Monika Žídková et al.•ARTICLE•Frontiers in Psychiatry•2017

    Methylone (3,4-methylenedioxy- N -methylcathinone) is a synthetic cathinone analog of the recreational drug ecstasy. Although it is marketed to recreational users as relatively safe, fatalities due to hyperthermia, serotonin syndrome, and multi-organ system failure have been reported. Since psychopharmacological data remain scarce, we have focused our research on pharmacokinetics, and on a detailed evaluation of temporal effects of methylone and …

  • Mephedrone (4-Methylmethcathinone)

    Open Access•Klára Šíchová, Nikola Pinterová et al.•ARTICLE•Frontiers in Psychiatry•2018

    Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH's and its primary metabolite nor-mephedrone's (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum, brain, lungs, and liver), as well as comparative analysis of their effects on locomotion [open field test (OFT)] and sensorimotor gating [prepulse i…

  • Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat

    Open Access•Rachel R Horsley, Eva Lhotková et al.•ARTICLE•Frontiers in Psychiatry•2018

    3,4-methylenedioxypyrovalerone (MDPV) is a potent pyrovalerone cathinone that is substituted for amphetamines by recreational users. We report a comprehensive and detailed description of the effects of subcutaneous MDPV (1-4 mg/kg) on pharmacokinetics, biodistribution and metabolism, acute effects on thermoregulation under isolated and aggregated conditions, locomotion (open field) and sensory gating (prepulse inhibition, PPI). All studies used m…

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

    Open Access•Guy M Goodwin, Scott T Aaronson et al.•ARTICLE•New England Journal of Medicine•2022

    BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression. METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formulation of psilocybin at a dose of 25 mg, 10 mg, or 1 mg (control), along with psychological support. The primary end point was the change from baseline to week 3 in the total score on the Montgomery-Å…

  • Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic

    Open Access•Zuzana Postránecká, Matyáš Lucký et al.•ARTICLE•Journal of Psychedelic Studies•2026

    The Czech Republic, like many European countries, continues to face significant challenges in treating substance use disorders (SUDs), with high relapse rates and complex comorbidities often linked to trauma and mental illness. Psychedelic-assisted psychotherapy (PAP) has re-emerged internationally as a promising therapeutic modality, although available evidence remains heterogeneous across substances, populations, and study designs. This narrati…

Forensic Toxicology and Drug Analysis (5 works) · Psychedelics and Drug Studies (5 works) · Chemistry (3 works) · Medicine (3 works) · Neurotransmitter Receptor Influence on Behavior (3 works) · Pharmacokinetics (3 works) · Pharmacology (3 works) · Amphetamine (2 works) · Cathinone (2 works) · Dopamine (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae